Amid volatility, healthcare’s appeal grows
WEBCAST: Amid volatility, healthcare's appeal grows
21 minute watch
Amid an environment of higher-than-expected inflation, rate hikes and a slowing global economy, health care’s defensive nature may offer attractive characteristics. In our view, depressed valuations and accelerating innovation make biotech particularly appealing, while other areas of healthcare could continue to shine near term.
Watch here as Portfolio Manager Andy Acker explains why the sector could offer both defence against market volatility and opportunities for long-term gains.
These are the views of the author at the time of publication and may differ from the views of other individuals/teams at Janus Henderson Investors. References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.
The information in this article does not qualify as an investment recommendation.
Marketing Communication.
21 minute watch